Enhanced Liver Fibrosis Panel as a Predictor of Liver Fibrosis in Chronic Hepatitis C Patients

Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C., Hepatology, 38, 1449, 10.1053/jhep.2003.09022

Strader DB WT, Thomas, 2004, Diagnosis, management, and treatment of hepatitis C., Hepatology, 39, 1147, 10.1002/hep.20119

Mehta, 2009, . Exceeding the limits of liver histology marker., J Hepatol, 50, 36, 10.1016/j.jhep.2008.07.039

Bravo, 2001, Liver biopsy., N Engl J Med, 344, 495, 10.1056/NEJM200102153440706

Castera, 2011, How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography versus liver biopsy Liver Int., , 31, 13

Bedossa, 2009, Assessment of hepatitis C:non-invasive fibrosis markers andor liver biopsy., Liver Int, 1, 19, 10.1111/j.1478-3231.2008.01940.x

Colloredo, 2003, . Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease., J Hepatol, 39, 239, 10.1016/S0168-8278(03)00191-0

Maharaj, 1986, . Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver., Lancet, 1, 523, 10.1016/S0140-6736(86)90883-4

Regev, 2002, . Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection., Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x

Goldin, 1996, . Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis., J Hepatol, 25, 649, 10.1016/S0168-8278(96)80234-0

Smith, 2009, Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C., Aliment Pharmacol Ther, 30, 557, 10.1111/j.1365-2036.2009.04062.x

Castera, 2012, Noninvasive methods to assess liver disease in patients with hepatitis B or C., Gastroenterology, 142, 1293, 10.1053/j.gastro.2012.02.017

Wai, 2004, . A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C., Hepatology, 38, 518, 10.1053/jhep.2003.50346

Shaheen, 2007, Diagnostic accuracy of the aspartate aminotransferaseto-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review., Hepatology, 46, 912, 10.1002/hep.21835

Forns, 2002, . Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model., Hepatology, 36, 986

Vallet-Pichard, 2007, . FIB-4: an inexpensive and accurate marker of fibrosis in HCV Infection. Comparison with liver biopsy and fibrotest., Hepatology, 46, 32, 10.1002/hep.21669

Lok, 2005, . Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C Cohort., Hepatology, 4, 282, 10.1002/hep.20772

Imbert-Bismut, 2001, . Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study., Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6

Cales, 2005, . A novel panel of blood markers to assess the degree of liver fibrosis., Hepatology, 42, 1373, 10.1002/hep.20935

Adams, 2005, . Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection., Clin Chem, 51, 1867, 10.1373/clinchem.2005.048389

Ledinghen, 2008, Transient elastography (FibroScan)., Gastroenterol Clin Bio, 32, 58, 10.1016/S0399-8320(08)73994-0

Friedrich-Rust, 2008, . Performance of transient elastography for the staging of liver fibrosis: a meta-analysis., Gastroenterology, 134, 960, 10.1053/j.gastro.2008.01.034

Castera, 2010, . Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations., Hepatology, 51, 828

Rosenberg, 2004, . Serum markers detect the presence of liver fibrosis: a cohort study., Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052

George, 2004, Expression of hyaluronic acid in Nnitrosodimethylamine induced hepatic fibrosis in rats., Int J Biochem Cell Biol, 36, 307, 10.1016/S1357-2725(03)00253-X

2011, Parkes J, Guha N, Roderick P, et al.. Enhanced liver fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C., J Vir Hepatitis, 18, 23, 10.1111/j.1365-2893.2009.01263.x

Guha, 2008, . Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the european liver fibrosis panel and exploring simple markers., Hepatology, 47, 455, 10.1002/hep.21984

Cobbold, 2010, . Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis C., J Vir Hepatitis, 17, 537, 10.1111/j.1365-2893.2009.01209.x

Friedrich-Rust, 2010, . Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis., BMC Gastroenterol, 10, 103, 10.1186/1471-230X-10-103

Crespo, 2012, . ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study., J Hepatol, 57, 281, 10.1016/j.jhep.2012.03.016

Wahl, 2012, . Biopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography., PLoS ONE, 7, e51906, 10.1371/journal.pone.0051906

Kim, 2012, . Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B., PLoS ONE, 7, e41964, 10.1371/journal.pone.0041964

Mayo, 2008, . Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay., Hepatology, 48, 1549, 10.1002/hep.22517

Guechot, 2012, . Independent validation of the enhanced liver fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C., Clin Chem Lab Med, 50, 693, 10.1515/cclm-2011-0858

Martinez, 2011, . Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C., Aliment Pharmacol Ther, 33, 138, 10.1111/j.1365-2036.2010.04500.x

Zarski, 2013, . Contribution of the ELFG test in algorithms of non-invasive markers towards the diagnosis of significant fibrosis in chronic hepatitis C., PLoS ONE, 8, e59088, 10.1371/journal.pone.0059088

Yoo, 2013, . Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea., Liver Int, 33, 706, 10.1111/liv.12136

Lichtinghagen, 2013, . The enhanced liver fibrosis (ELF) score: normal values, influence factors and proposed cut-off values., J Hepatol, 59, 236, 10.1016/j.jhep.2013.03.016

Bedossa, 1996, An algorithm for the grading of activity in chronic hepatitis C., Hepatology, 24, 289, 10.1002/hep.510240201

Castera, 2005, . Prospective comparison of transient elastography, Fibrotest,APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C., Gastroenterology, 128, 343, 10.1053/j.gastro.2004.11.018

Obuchowski, 2005, Estimating and comparing diagnostic tests accuracy when the gold standard is not binary., Acad Radiol, 12, 1198, 10.1016/j.acra.2005.05.013

Lambert, 2008, . How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited., Clin Chem, 54, 1372, 10.1373/clinchem.2007.097923

Catanzaro, 2013, . Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C., Hepatobiliary Pancreat Dis Int, 12, 500, 10.1016/S1499-3872(13)60079-X

Sebastiani, 2011, . The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases., Aliment Pharmacol Ther, 34, 1202, 10.1111/j.1365-2036.2011.04861.x